Edwards Lifesciences reported $542.1M in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2545M 1153M
Abiomed ABMD:US $ 60.44M 109.72M
Atricure ATRC:US $ 98.67M 113.75M
Baxter International BAX:US $ 495M 71M
Becton, Dickinson and BDX:US $ 495M 133M
Boston Scientific BSX:US $ 387M 125M
Cardiovascular Systems CSII:US $ -8.12M 3.21M
Cooper Companies COO:US $ 100.6M 42.6M
Dexcom DXCM:US $ 117.5M 16.5M
Globus Medical GMED:US $ 53.33M 7.45M
Hill Rom HRC:US $ 114.1M 34.5M
Hologic HOLX:US $ 439.5M 80.9M
Inogen INGN:US $ 6.37M 5.3M
Insulet PODD:US $ 32.2M 46M
Integra Lifesciences IART:US $ 57.76M 5.42M
Intuitive Surgical ISRG:US $ 442.6M 68.6M
Johnson & Johnson JNJ:US $ 3849M 2813M
Masimo MASI:US $ 67.61M 2.48M
Medtronic MDT:US $ 1563M 704M
Merit Medical Systems MMSI:US $ 15.93M 7.04M
Nuvasive NUVA:US $ -6.63M 17.38M
Stryker SYK:US $ 574M 155M
Tandem Diabetes Care TNDM:US $ 7.72M 2.29M
Teleflex TFX:US $ 240.98M 125.34M
Zimmer Biomet Holdings Inc ZBH:US $ 214.9M 5.6M